MedTrace Logo

Clinical Trials

NCT05163639 | RECRUITING | EARLY_PHASE1
92 participants

Spinal Cord Associative Plasticity Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2021-09-10
Completion:
2027-12-30
Conditions
  • Cervical Spinal Cord Injury
  • Tetraplegia/Tetraparesis
  • Cervical Myelopathy
Interventions
  • PROCEDURE
No Results Yet
NCT04986579 | RECRUITING | PHASE2
120 participants

Scalp Cooling in MBC

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2021-10-07
Completion:
2028-06-01
Conditions
  • Metastatic Breast Cancer
  • Chemotherapy-induced Alopecia
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT04715958 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
122 participants

SHAPE Neoadjuvant Chemotherapy Response

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2020-12-07
Completion:
2026-10-31
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Locally Advanced Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04677309 | COMPLETED
32 participants

Lung Ultrasound to Assess Aeration Loss After Lung Resection Surgery

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-18
Start Date:
2020-12-20
Completion:
2022-01-30
Conditions
  • Lung Neoplasm
  • Lung Cancer
  • Lung Resection Surgery
  • Thoracic Surgery
  • One-lung Ventilation (OLV)
  • Postoperative Pulmonary Complications (PPCs)
  • Lung Ultrasound
  • Lung Ultrasound Score
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04623775 | COMPLETED | PHASE2
468 participants

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2021-02-17
Completion:
2024-01-11
Conditions
  • Non-small Cell Lung Cancer
  • Recurrent Non-small Cell Lung Cancer
  • Metastatic Non-small Cell Lung Cancer
Interventions
  • BIOLOGICAL
  • DRUG
Results Available
NCT04616248 | ACTIVE_NOT_RECRUITING | PHASE1
14 participants

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2023-01-09
Completion:
2027-01-09
Conditions
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Breast Carcinoma
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Unresectable Breast Carcinoma
  • Metastatic Melanoma
  • Unresectable Melanoma
  • Cutaneous Squamous Cell Carcinoma
  • Merkel Cell Carcinoma
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sarcoma,Soft Tissue
  • Sarcoma of Bone
  • Basal Cell Carcinoma
Interventions
  • DRUG
  • RADIATION
  • BIOLOGICAL
No Results Yet
NCT04576455 | ACTIVE_NOT_RECRUITING | PHASE2
303 participants

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-18
Start Date:
2020-11-27
Completion:
2022-02-18
Conditions
  • Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Interventions
  • DRUG
Results Available
NCT04573699 | COMPLETED
34 participants

Cardiac Neuromodulation for Heart Failure

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-18
Start Date:
2020-12-15
Completion:
2022-12-15
Conditions
  • Heart Failure NYHA Class II
  • Heart Failure NYHA Class III
Interventions
  • DEVICE
No Results Yet
NCT04530799 | COMPLETED
241 participants

Prospective Observational Trial of IAPA

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-18
Start Date:
2022-03-10
Completion:
2026-05-18
Conditions
  • Influenza With Pneumonia
  • Pulmonary Aspergillosis
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page